K. Buchholtz

The effect of basal–bolus therapy varies with baseline 1,5‐anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis

P. Raskin, S. Heller, T. Pieber, 2018, Diabetic Medicine.

Fast‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: Efficacy and safety from a randomized double‐blind trial

J. Buse, T. Kadowaki, M. Komatsu, 2018, Diabetes, obesity & metabolism.

Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements

S. I. Moreno, K. Buchholtz, P. Johansen, 2020, PharmacoEconomics.

Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials

T. Pieber, A. Gorst-rasmussen, T. Kadowaki, 2019, Diabetes Therapy.